The Evolution and Improvements in Pediatric Oncology with Adam Green, MD, and Kelly Faulk, MD (S5:E36)

Today's episode is underwritten by Aflac, a proud supporter of Charting Pediatrics and Children's Hospital Colorado. For more than 20 years, Aflac has dedicated its heart and philanthropic mission to helping children with cancer. Thank you to Aflac for envisioning a world without pediatric cancer by supporting our Center for Cancer and Blood Disorders. Please visit our Charting Pediatrics website to learn more about becoming an underwriting sponsor.

Pediatric cancer is a devastating diagnosis that thousands of patients and families receive a year. When faced with such a diagnosis, it is crucial that patients and families have access to the most current and effective treatment options as possible.  In the past few decades, pediatric cancer survival rates have improved immensely. Today, we are going to be discussing the treatment options, clinical trials, and the disparities and equity in pediatric oncology.

Today, I am happy to be speaking with my collogues Dr. Adam Green and Dr. Kelly Faulk.

Both Dr. Green and Dr. Faulk are a part of the Center for Cancer and Blood Disorders Team at Children’s Hospital Colorado. Dr. Green specializes in Pediatric Oncology and is an Associate Professor of Pediatrics at the University of Colorado School of Medicine. Dr. Faulk is also an Assistant Professor of Pediatrics and specialize in pediatric Leukemia and Lymphoma, with research focused on early phase trial design and experimental therapeutics for high risk forms of leukemia.